What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 in related Notification /order dated 12.06.2018. S.No S.O.No Date Formulation based on bulk drugs 1 2398 (E) 12.06.2018 Retail prices of 20 formulations under (Prices Control) Order,2013. 2 2399 (E) 12.06.2018 Ceiling prices of 02 formulations under (Prices Control) Order,2013. 3 2400 (E) 12.06.2018 Corrigendum to S.O.No 1461(E) dated 2nd April 2018 S.O 2398 (E) In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30 th May, 2013 and S. O. 701(E) dated 10 th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; Sl. No. Name of the Scheduled Formulation/ Brand Name 1 Methylcobalamin + Alpha Lipoic Acid + Pyridoxine Hydrochloride + Folic Acid + Vitamin D3 1000IU Tablet 2 Methylcobalamin + Alpha Lipoic Acid + Pyridoxine Hydrochloride + Folic Acid + Vitamin D3 1000IU Tablet Unit manufacturer & marketing company respectively contains: Methylcobalamin IP 1500mcg, Alpha Lipoic Acid USP 100mg, Pyridoxine Acid IP 1.5mg Vitamin D3 1000IU contains: Methylcobalamin IP 1500mcg, Alpha Lipoic Acid USP 100mg, Pyridoxine Acid IP 1.5mg Vitamin D3 1000IU 1 Tablet M/s Sozin Flora Pharma LLP / M/s Zydus Healthcare Ltd 1 Tablet M/s Mascot Health Series Pvt. Ltd / M/s Zydus Healthcare Retail Price (Rs.) 10.31 10.31
3 Cefixime + Cloxacillin + Lactic Acid Tablet (ZIFI LBX +200) 4 Omeprazole + Domperidone Capsule (OZSON-DSR) 5 Clotrimazole + Beclomethasone Cream (CZSON-B) 6 Clotrimazole + Beclomethasone + Neomycin Cream (CZSON -NB) 7 Linezolid Suspension (ZIFI TURBO KID) contains: Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200mg, Cloxacillin Sodium IP eq. to Cloxacillin 500mg (in Extended Release form), Lactic Acid Bacillus 90 Million Spores Each hard gelatin capsule contains: Omeprazole 20mg (As enteric coated pellets), Domperidone (As Sustained Release Pallets) 30mg Cream contains: Clotrimazole 1.0% w/w + Beclomethasone Dipropionate 0.025% w/w Cream contains: Clotrimazole 1.0% w/w + Beclomethasone Dipropionate 0.025% w/w, Neomycin Sulphate eq. to Neomycin Base 0.5w/w Cream Each 5ml of the reconstituted suspension contains: Linezolid IP 100mg in a flavored base 8 Linezolid Suspension (LIZOFLY) Each 5ml of the reconstituted suspension contains: Linezolid IP 100mg in a flavored base 9 Rosuvastatin + Clopidogrel Tablet (ROSUVAS CV 10) 10 Olmesartan + Amlodipine + Amlodipine Tablet (Triolmezest CH 20) 11 Olmesartan + Amlodipine + Amlodipine Tablet (Triolmezest CH 40) 12 Telmisartan + Amlodipine + Chlorthalidone Tablet (Telvas 3D CT 40/6.25) 13 Telmisartan + Amlodipine + Chlorthalidone Tablet (Telvas 3D CT 80/6.25) contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg, Clopidogrel Bisulfate IP eq. to Clopidogrel 75mg contains: Olmesartan IP 20 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg Chlorthalidone IP 12.5 mg contains: Olmesartan IP 40 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg Chlorthalidone IP 12.5 mg contains: Telmisartan 40mg, Amlodipine 5mg & Chlorthalidone 6.25mg contains: Telmisartan 80mg, Amlodipine 5mg & Chlorthalidone 6.25mg 1 Tablet M/s Malik Lifesciences Pvt. / M/s FDC Limited 1 Capsule M/s Unison Pharmaceuticals Pvt. 1 GM M/s Tuton Pharmaceuticals / M/s Unison Pharmaceuticals Pvt. 1 GM M/s Tuton Pharmaceuticals / M/s Unison Pharmaceuticals Pvt. 1 ML M/s Theon Pharmaceuticals / M/s FDC Limited M/s Sava Healthcare /M/s Brinton Pharmaceuticals 1 ML 1 Tablet M/s Pure and Cure Healthcare Pvt. /M/s Sun Pharmaceutical Industries Pharmaceuticals / M/s Sun Pharma Laboratories Pharmaceuticals / M/s Sun Pharma Laboratories Pharmaceuticals / M/s Aristo Pharmaceuticals Pvt. Pharmaceuticals /M/s Aristo Pharmaceuticals Pvt. 11.480 2.68 2.15 1.93 2.77 2.77 10.96 8.78 15.53 8.63 14.40
14 Norethisterone Tablet Each film coated controlled release table contains: Norethisterone Acetate BP 10mg Tablet 15 Alpha Lipoic + Vitamin D3 + Pyridoxine+ Mecobalamin + Folic Acid + Biotin Tablet (Nervijen D3) 16 Omega -3 (Eicosapentaenoic + Docosahexaenoic) + Mecobalamine + Pyridoxine + Folic Acid + Vitamin E + Vitamin C + Zinc Sulphate + Sodium selenite Capsule (Omegaful) Each coated tablet contains: Alpha Lipoic Acid 200mg Vitamin D3 1000 IU Pyridoxine HCl 3mg Mecobalamin 1500mcg Folic Acid 1.5mg Biotin 200mcg Each soft gelatine Capsule contains: Omega -3 Acid Ethyl Esters 60 BP providing Eicosapentaenoic Acid 90mg, Docosahexaenoic Acid 60mg, Mecobalamin-500mcg, Pyridoxine Acid 1.5mg, Vitamin E 25IU, Vitamin C 100mg, and Zinc Sulphate IP eq. to Elemental Zinc 15mg Sodium selenite pentahydrate BP eq. to Elemental Selenium 60mcg 17 Thiamine Mononitrate + Pyridoxine Hydrochloride + Cyanocobalamin + Nicotinamide + Calcium Pantothenate + Riboflavin + Vitamin C + Folic Acid Tablet (Sioneuron F) contains: Thiamine Mononitrate IP 10mg, Pyridoxine Hydrochloride IP 3mg, Cyanocobalamin IP 15mcg, Nicotinamide IP 100mg, Calcium Pantothenate IP 50mg, Riboflavin IP 10mg, Vitamin C IP 150mg, Folic Acid IP 1500mcg 18 Tenofovir Disoproxil Fumarate + Lamividine + Efavirenz Tablet (AVONZA) Each tablet contains: Tenofovir Disoproxil Fumarate 300mg, Lamividine 300mg, Efavirenz 400mg Pharmaceuticals /M/s Obsurge Biotech Limited Pharmaceuticals /M/s Jenburkt Pharmaceuticals Ltd 1 Capsule M/s Mankind Pharma / M/s Magnet Labs Pvt. 12.89 3.06 1.56 1 Tablet M/s Albert David Limited 1.55 1 Tablet M/s Mylan Laboratories Limited /M/s Mylan Pharmaceutical Pvt. 60.00 19 Diclofenac + Methyl Salcylate + Menthol (Volini Maxx Spray in 25gm Pack) 20 Diclofenac + Methyl Salcylate + Menthol (Volini Maxx Spray in 55gm Pack) contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salicylate IP 10% w/w & Menthol IP 5% w/w contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salicylate IP 10% w/w & Menthol IP 5% w/w 25 GM M/s Sun Pharmaceuticals Industries 55 GM M/s Sun Pharmaceuticals Industries 156.25 296.87
S.O. 2399 (E)- In implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP) vide order(s) specified in column (6) of the table here in below passed by the Department of Pharmaceuticals under para 31 of Drugs (Prices Control) Order, 2013 and in exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March,2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) specified in the Column (7) of the table regarding formulation specified in mentioned in the table in so far as it relates to formulation pack mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes /revises the price as specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulation(s) specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: Sl. No. Name of the Scheduled Formulation 1 Oral Rehydration Salt (ORS) 2 Co -trimoxazole (Sulphamethoxazole (A)+Trimethoprim (B)] Dosage form & Unit /packagi ng Ceiling Price (Rs.) Review Order number and date As Licensed 1 GM 0.83 31015/30/2016-PI dated 08.06.2016 Tablet 800 mg(a)+160 mg(b) 1 Tablet 1.27 31015/33/2017-Pricing dated 24.8.2017 and 31015/82/2016-PI.I dated 5.4.2017 Existing SO number and date 1461 (E) dated 02.04.2018 (at Sl. No. 594) 1461 (E) dated 02.04.2018 (at Sl. No. 223) SO 2400 (E) In the National Pharmaceutical Pricing Authority's notification S.O. 1461(E) dated 2nd April 2018, relating to the ceiling price fixation /revision of Anti-tetanus based on WPI, published in the Gazette of India, Extraordinary, of the Entry at Sl. No. 60 of the table be read as follows:: Instead of Unit Ceiling price (wef 01.4.2018 with WPI @ 3.43812%) Existing SO number and date 1 2 3 4 5 6 (a) 6 (b) 60 Anti - tetanus Each Pack 773.78 3,090 20.09.2017 Read as Unit Ceiling price (wef 01.4.2018 with WPI @ 3.43812%) Existing SO number and date 1 2 3 4 5 6 (a) 6 (b) 60 Anti - tetanus 250 IU Each Pack 773.78 3,090 20.09.2017
Further, in the National Pharmaceutical Pricing Authority's notification S.O. 3090(E) dated 20th September 2017, relating to the ceiling price fixation/revision of Anti- tetanus, published in the Gazette of India, Extraordinary, of the Entry at Sl. No. 9 of the table be read as follows: Instead of Read as Unit Ceiling price 1 2 3 4 5 9 Anti -tetanus Each Pack 748.06 Unit Ceiling price 1 2 3 4 5 9 Anti -tetanus 250 IU Each Pack 748.06 Click the following links for Notifications Retail prices of 20 formulations under (Prices Control) Order,2013. Ceiling prices of 02 formulations under (Prices Control) Order,2013. Corrigendum to S.O.No 1461(E) dated 2nd April 2018